Tag Archives: ERT

FDA Grants Priority Review to Sanofi’s Investigational Oral Therapy Venglustat for Type 3 Gaucher Disease

(IN BRIEF) Sanofi has received FDA priority review for the new drug application for venglustat, an investigational oral glucosylceramide synthase inhibitor being developed for type 3 Gaucher disease. The FDA’s target action date is 25 November 2026. If approved, venglustat … Read the full press release

Iberdrola chairman urges faster electrification and stronger grid investment at European industry summit in Sweden

(IN BRIEF) Iberdrola Executive Chairman Ignacio Galán has called for faster electrification, stronger electricity grid investment and simplified administrative procedures during the European Round Table for Industry plenary meeting in Sweden. Speaking alongside European Commission President Ursula von der Leyen … Read the full press release